October 10 - 12, 2018
University of Colorado Denver
Precision medicine has made significant inroads in the management of patients around the world, but mainly in oncology. Auto-immunologists at the University of Colorado Denver, however, truly believe that there is a strong need for precision medicine approaches that can improve the care of individuals with autoimmune diseases or even lead to disease prevention.
To help address this unmet need, the Precision Medicine in Auto-immunity meeting is dedicated to understanding the relevance of biomarkers in the prevention, diagnosis and management of autoimmune diseases. The focus of the first meeting will be on using auto-antibodies, other biomarkers and data sources (e.g. companiondiagnostics) in three disease areas: rheumatoid arthritis, systemic lupus erythematosus,and the antiphospholipid antibody syndrome.
The meeting will consist of state-of-the-art presentations and panel discussions provided by world experts in autoimmune disorders. The keynote speaker will be Harry Glorikian, author of the best-selling Moneyball Medicine: Thriving in the New Data-Driven Healthcare Market.